CTOs on the Move

American Hospital Service Group

www.ahsg.us

 
American Hospital Service Group is a Exton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.ahsg.us
  • 415 Eagleview Blvd Ste 108
    Exton, PA USA 19341
  • Phone: 610.524.2400

Executives

Name Title Contact Details

Similar Companies

Conkerexe Biosciences

Conkerexe Biosciences is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carecor Health Services

Carecor Health Services Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kemberton

Kemberton is a leading provider of technology-enabled revenue cycle management services to hospitals for complex claims. We specialize in the management and collection of workers compensation, motor vehicle accident claims, veteran administration and the resolution of insurance denials for hospitals and physician practice groups. Kemberton helps accelerate collection times and maximize reimbursements for over 300 hospital clients across 35 states, resulting in over $1.5 billion dollars of incremental cash payments for our clients.

Lafayette General Health

Lafayette General Health is Acadianas largest non-profit, community-owned regional health system committed to always delivering excellence. The system has over 4,000 employees, serving the south-central region of Louisiana by aligning with facilities across Acadiana. Lafayette General Health is a founding member of the Ochsner Health Network.

Voyager Therapeutics

Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.